drugset
drugset / Trial / NCT06472739

The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy

NCT06472739 ↗

Phase 2 Unknown 138 enrolled Sun Yat-sen University
RandomizedParallel-groupOpen-labelPrevention

Summary

To evaluate the efficacy of GM-CSF to preventing oral mucositis for patients with nasopharyngeal carcinoma receiving radiotherapy.

Timeline

Start
2023-09-15
Primary completion
2024-08-15
Completion
2024-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject sargramostim Protein / enzyme biologic — Other

Indications

No indication recorded.